Continuous renal replacement therapy in critically ill children: single-center experience

Background/aim: Continuous renal replacement therapy (CRRT) has significant benefits in the treatment of critically ill children. The objective of this study is to describe the treatment indications, methods, demographics, and outcome of the patients who received CRRT in our pediatric intensive care unit and neonatal care unit, and, according to these results, we also aimto make improvements in our unit-based interventions. Materials and methods: In this single-centered study, we retrospectively evaluated medical charts of the patients admitted to our intensive care units and received CRRT between February 2010 and November 2015. Results: Fifty of 60 patients were included in this study. Newborns made up 28% (n = 14) of the patients. The mean body weight was 18.4 kg (2.3-98 kg). CRRT indications were fluid overload (30%), acute kidney injury (40%), metabolic disease (24%), electrolyte impairment (4%), and drug intoxication (2%). The most common method of CRRT was continuous venovenous hemodiafiltration (CVVHDF) (72%). The mean duration of CRRT was 135 hours (1-864) and totally 143 filters, polyarylethersulfon (n = 23.46%) and polyacrylonitrile (n = 27.54%) were used. Overall survival was 42%. The survival rate of newborns was significantly higher (P = 0.046). Conclusion: CRRT is a lifesaving method that can be applied to critically ill children with acute kidney injury and fluid overload at any age and weight by experienced teams.Key words: Continuous renal replacement therapy, acute kidney injury, critically ill children, fluid overload, hemodiafiltration, hemofiltration

PDF

___

1. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. American Journal of Kidney Diseases 2010; 55 (2): 316-325. doi: 10.1053/j.ajkd.2009.10.048
2. Pathak S, Pandey SS, Lazarus M, Mudey A, Nagrale A. Incidences and clinical outcomes of acute kidney injury in PICU: a prospective observational study. International Journal of Medical and Health Sciences 2017; 6: 101-105.
3. Sethi SK, Chakraborty R, Joshi H, Raina R. Renal replacement therapy in pediatric acute kidney injury. Indian Journal of Pediatrics 2020; 87 (8): 608-617. doi: 10.1007/s12098-019- 03150-9
4. Aygün F, Varol F, Durak C, Petmezci MT, Kacar A et al. Evaluation of continuous renal replacement therapy and therapeutic plasma exchange, in severe sepsis or septic shock in critically ill children. Medicina 2019; 55 (7): 350-365. doi: 10.3390/medicina55070350
5. Lopes CLS, Piva JP. Fluid overload in children undergoing mechanical ventilation. Revista Brasileira de Terapia Intensiva 2017; 29 (3): 346-353. doi: 10.5935/0103-507X.20170045
6. Potter DE, San Luis E, Wipfler JE, Portale AA. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis in children. Kidney International Supplement 1986; 19: 11-14.
7. Luckritz KE, Symons JM. Renal Replacement Therapy in the ICU. In: Kiessling SG, Goebel J, Somers MJG (editors). Pediatric Nephrology in the ICU. 1st ed Berlin, Heidelberg: Springer Berlin Heidelberg 2009. pp 115-125.
8. Flynn JT. Choice of dialysis modality for the management of pediatric acute renal failure. Pediatric Nephrology 2002; 17 (1): 61-69. doi: 10.1007/s004670200011
9. Soler YA, Nieves-Plaza M, Prieto M, Garcia-De Jesus R, Suarez-Rivera M. Pediatric risk, injury, failure, loss, end-stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study. Pediatric Critical Care Medicine 2013; 14 (4) :189-195. doi: 10.1097/ PCC.0b013e3182745675
10. Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clinical Journal of the American Society of Nephrology 2007; 2 (4): 732-738. doi: org/10.2215/CJN.03200906
11. Goldstein SL, Currier H, Graf JM, Cosio CC, Brewer ED et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001; 107 (6): 1309-1312. doi: 10.1542/peds.107.6.1309
12. Sık G, Demirbuga A, Günhar S, Nisli K, Cıtak A. clinical features and indications associated with mortality in continuous renal replacement therapy for pediatric patients. Indian Journal of Pediatrics 2019; 86 (4): 360- 364. doi: 10.1007/s12098-019- 02868
13. Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M et al. Continuous renal replacement therapy for children
14. Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJ et al. Continuous renal replacement therapy in children up to 10 kg. American Journal of Kidney Diseases 2003; 41 (5): 984- 989. doi: 10.1016/s0272-6386(03)00195-1
15. Demirkol D, Aktuğlu ZÇ, Karacabey BN, Cesur Y, Ataman Y et al. The role of supportive treatment in the management of hyperammonemia in neonates and infants. Blood Purification 2019; 48 (2):150-157. doi: 10.1159/000495021
16. Goldstein SL, Somers MJ, Brophy PD, Bunchman TE, Baum M et al. The prospective pediatric continuous renal replacement therapy (ppcrrt) registry: design, development, and data assessed. The International Journal of Artificial Organs 2004; 27 (1): 9-14. doi: 10.1177/039139880402700104
17. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT registry group. Pediatric Nephrology 2008; 23 (4): 625- 630. doi: 10.1007/s00467-007-0672-2
18. Aslan N, Yildizdas D, Atmis B, Horoz OO, Haytoglu Z et al. Evaluation of patients undergoing continuous renal replacement therapy due to acute kidney injury in our pediatric intensive care unit. Journal of Anesthesia & Intensive Care Medicine 2019; 9 (5): 555771. doi:10.19080/JAICM.2019.09.555771
19. Fargason CA, Langman CB. Limitations of the pediatric risk of mortality score in assessing children with acute renal failure. Pediatric Nephrology 1993; 7 (6): 703-707. doi: 10.1007/ BF01213327
20. Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney International 2005; 67 (2): 653-658. doi: 10.1111/j.1523- 1755.2005.67121.x
21. Fleming GM, Walters S, Goldstein SL, Alexander SR, Baum MA et al. Nonrenal indications for continuous renal replacement therapy: a report from the prospective pediatric continuous renal replacement therapy registry group. Pediatric Critical Care Medicine 2012;13 (5): 299-304. doi: 10.1097/ PCC.0b013e31824fbd76
22. Hackbarth R, Bunchman TE, Chua AN, Somers MJ, Baum M et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. The International Journal of Artificial Organs 2007; 30 (12):1116-1121. doi: 10.1177/039139880703001212
23. Del Castillo J, López-Here J, Cidoncha E, Urbano J, Mencía S et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Critical Care 2008; 12 (4): 93-100. doi: 10.1186/cc6965
24. Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, del Castillo J et al. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Critical Care 2009; 13 (6): R184. doi: 10.1186/cc8172